Cargando…

Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson’s Disease

Background: The most established pathognomonic protein of Parkinson’s disease (PD), α-synuclein, is extensively investigated for disease diagnosis and prognosis; however, investigations into whether the free form of α-synuclein in the blood functions as a PD biomarker have not been fruitful. Extrace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Chen-Chih, Chan, Lung, Chen, Jia-Hung, Hung, Yi-Chieh, Hong, Chien-Tai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155846/ https://www.ncbi.nlm.nih.gov/pubmed/34067663 http://dx.doi.org/10.3390/biom11050744

Ejemplares similares

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease
por: Chung, Chen-Chih, et al.
Publicado: (2020)

Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study
por: Chan, Lung, et al.
Publicado: (2023)

Cytokine Profile in Plasma Extracellular Vesicles of Parkinson’s Disease and the Association with Cognitive Function
por: Chan, Lung, et al.
Publicado: (2021)

Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson’s disease
por: Chan, Lung, et al.
Publicado: (2023)

α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
por: Wang, Pan, et al.
Publicado: (2023)

Altered Insulin Receptor Substrate 1 Phosphorylation in Blood Neuron-Derived Extracellular Vesicles From Patients With Parkinson’s Disease
por: Chou, Szu-Yi, et al.
Publicado: (2020)

Plasma Exosomal Brain-Derived Neurotrophic Factor Correlated with the Postural Instability and Gait Disturbance–Related Motor Symptoms in Patients with Parkinson’s Disease
por: Chung, Chen Chih, et al.
Publicado: (2020)

Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
por: Chen, Jia-Hung, et al.
Publicado: (2021)

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
por: Liu, Zongran, et al.
Publicado: (2022)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation
por: Kunadt, Marcel, et al.
Publicado: (2015)

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease
por: Chen, Nai-Ching, et al.
Publicado: (2020)

Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease
por: Yan, Shijun, et al.
Publicado: (2023)

Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells
por: Gustafsson, Gabriel, et al.
Publicado: (2018)

Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers
por: Yan, Shijun, et al.
Publicado: (2023)

Poly (ADP-Ribose) and α–synuclein extracellular vesicles in patients with Parkinson disease: A possible biomarker of disease severity
por: Lucien, Fabrice, et al.
Publicado: (2022)

Extracellular α-synuclein levels are regulated by neuronal activity
por: Yamada, Kaoru, et al.
Publicado: (2018)

A minute fraction of α-synuclein in extracellular vesicles may be a major contributor to α-synuclein spreading following autophagy inhibition
por: Taha, Hash Brown, et al.
Publicado: (2022)

Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease
por: Chen, Wei-Ru, et al.
Publicado: (2022)

Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
por: Chang, Chih-Jung, et al.
Publicado: (2021)

Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

An intact membrane is essential for small extracellular vesicle‐induced modulation of α‐synuclein fibrillization
por: Ugalde, Cathryn L., et al.
Publicado: (2020)

Basics and applications of tumor-derived extracellular vesicles
por: Tai, Yu-Ling, et al.
Publicado: (2019)

Outcomes of Endovascular Treatment versus Standard Medical Treatment for Acute Ischemic Stroke with Basilar Artery Occlusion: A Systematic Review and Meta-Analysis
por: Chen, Jia-Hung, et al.
Publicado: (2023)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis
por: Chen, Jia-Hung, et al.
Publicado: (2022)

The effect of monoamine oxidase-B inhibitors on the alleviation of depressive symptoms in Parkinson’s disease: meta-analysis of randomized controlled trials
por: Huang, Yao Hsien, et al.
Publicado: (2021)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins
por: Carnazza, Kathryn E., et al.
Publicado: (2022)

Retinal Diseases and Parkinson Disease: A Population-Based Study
por: Chen, Po-Chih, et al.
Publicado: (2021)

Cell Responses to Extracellular α-Synuclein
por: Surguchev, Alexei A., et al.
Publicado: (2019)

Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
por: Fan, Zheng, et al.
Publicado: (2020)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
por: Ishii, Ryotaro, et al.
Publicado: (2015)

Newly Diagnosed Anemia Increases Risk of Parkinson’s disease: A Population-Based Cohort Study
por: Hong, Chien Tai, et al.
Publicado: (2016)

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
por: Foulds, Penelope G., et al.
Publicado: (2013)

Plasma α‐synuclein levels are increased in patients with obstructive sleep apnea syndrome
por: Sun, Hao‐Lun, et al.
Publicado: (2019)

Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s disease
por: Fonseca-Ornelas, Luis, et al.
Publicado: (2021)

Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease
por: Vacchi, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fbook7ll79i4spiv5f9tbuufn9